Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2024 ∙ Alper, L. Oron, Y. Handzel, O. Abu-Eta, R. Muhanna, N. Ungar, O. J.
Idiopathic sudden sensorineural hearing loss after COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Lamichhane, P. Khalid, H. Siviyachan, C. K. Zafar, S. Prasanth, M. Khanal, K. Agrawal, A. Kaur Jhajj, L.
Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
2024 ∙ Hua, T. Fan, R. Fan, Y. Chen, F.
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Chue, W. X. Lienardi, L. A. Tan, T. Q. W. Kadir, I. A. Lam, J. C. M.
Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
2024 ∙ Bytyci, J. Ying, Y. Lee, L. Y. W.
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Tian, Z. Chen, Y. Yao, Y. Chen, L. Zhu, X. Shen, Z. Yang, S. Jin, H.
Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Ma, B. M. Tam, A. R. Chan, K. W. Hung, I. F. N. Tang, S. C. W. Chan, T. M. Yap, D. Y.
Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2024 ∙ Ouyang, L. Lei, G. Gong, Y.
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Kavikondala, S. Haeussler, K. Wang, X. Spellman, A. Bausch-Jurken, M. T. Sharma, P. Amiri, M. Krivelyova, A. Vats, S. Nassim, M. Kumar, N. Van de Velde, N.
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Chenchula, S. Chandra, M. B. Adusumilli, M. B. Ghanta, S. N. Bommasani, A. Kuttiappan, A. Padmavathi, R. Amerneni, K. C. Chikatipalli, R. Ghanta, M. K. Reddy, S. S. Mythili Bai, K. Prakash, S. Jogender, G. Chavan, M. Balakrishnan, S.
Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review
All age groups COVID-19 Efficacy/effectiveness Administration Safety
Rating:
Critically low
Loading...